Papers
Topics
Authors
Recent
Search
2000 character limit reached

Meply: A Large-scale Dataset and Baseline Evaluations for Metastatic Perirectal Lymph Node Detection and Segmentation

Published 13 Apr 2024 in cs.CV and cs.LG | (2404.08916v1)

Abstract: Accurate segmentation of metastatic lymph nodes in rectal cancer is crucial for the staging and treatment of rectal cancer. However, existing segmentation approaches face challenges due to the absence of pixel-level annotated datasets tailored for lymph nodes around the rectum. Additionally, metastatic lymph nodes are characterized by their relatively small size, irregular shapes, and lower contrast compared to the background, further complicating the segmentation task. To address these challenges, we present the first large-scale perirectal metastatic lymph node CT image dataset called Meply, which encompasses pixel-level annotations of 269 patients diagnosed with rectal cancer. Furthermore, we introduce a novel lymph-node segmentation model named CoSAM. The CoSAM utilizes sequence-based detection to guide the segmentation of metastatic lymph nodes in rectal cancer, contributing to improved localization performance for the segmentation model. It comprises three key components: sequence-based detection module, segmentation module, and collaborative convergence unit. To evaluate the effectiveness of CoSAM, we systematically compare its performance with several popular segmentation methods using the Meply dataset. Our code and dataset will be publicly available at: https://github.com/kanydao/CoSAM.

Citations (1)

Summary

No one has generated a summary of this paper yet.

Paper to Video (Beta)

No one has generated a video about this paper yet.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.

Collections

Sign up for free to add this paper to one or more collections.

Tweets

Sign up for free to view the 1 tweet with 0 likes about this paper.